Xponance’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
21,614
-557
| -3% | -$3.19K | ﹤0.01% | 1394 |
|
|
2025
Q1 | $181K | Buy |
22,171
+955
| +5% | +$7.79K | ﹤0.01% | 1284 |
|
|
2024
Q4 | $200K | Buy |
21,216
+2,249
| +12% | +$21.2K | ﹤0.01% | 1300 |
|
|
2024
Q3 | $203K | Buy |
18,967
+412
| +2% | +$4.4K | ﹤0.01% | 1254 |
|
|
2024
Q2 | $184K | Buy |
18,555
+936
| +5% | +$9.29K | ﹤0.01% | 1190 |
|
|
2024
Q1 | $208K | Buy |
17,619
+434
| +3% | +$5.11K | ﹤0.01% | 1184 |
|
|
2023
Q4 | $244K | Buy |
17,185
+678
| +4% | +$9.62K | ﹤0.01% | 1107 |
|
|
2023
Q3 | $201K | Buy |
16,507
+61
| +0.4% | +$742 | ﹤0.01% | 1123 |
|
|
2023
Q2 | $207K | Buy |
16,446
+461
| +3% | +$5.79K | ﹤0.01% | 1141 |
|
|
2023
Q1 | $177K | Buy |
15,985
+214
| +1% | +$2.37K | ﹤0.01% | 1134 |
|
|
2022
Q4 | $193K | Buy |
15,771
+263
| +2% | +$3.21K | ﹤0.01% | 1125 |
|
|
2022
Q3 | $162K | Buy |
15,508
+605
| +4% | +$6.32K | ﹤0.01% | 1093 |
|
|
2022
Q2 | $160K | Buy |
14,903
+2,396
| +19% | +$25.7K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $118K | Sell |
12,507
-59
| -0.5% | -$557 | ﹤0.01% | 1128 |
|
|
2021
Q4 | $145K | Buy |
12,566
+194
| +2% | +$2.24K | ﹤0.01% | 1134 |
|
|
2021
Q3 | $118K | Sell |
12,372
-1,799
| -13% | -$17.2K | ﹤0.01% | 1136 |
|
|
2021
Q2 | $137K | Buy |
+14,171
| New | +$137K | ﹤0.01% | 1200 |
|
|
2020
Q3 | – | Sell |
-11,866
| Closed | -$179K | – | 1031 |
|
|
2020
Q2 | $179K | Buy |
+11,866
| New | +$179K | ﹤0.01% | 986 |
|